Patients with type 2 diabetes and stable ischemic heart disease are at high risk for subsequent adverse cardiac outcomes. But 5-year data published in the June 11, 2009, issue of the New England of Journal of Medicine shows that optimal medical therapy with or without prompt revascularization (a mix of CABG and PCI) achieves similar rates of death and major cardiovascular events in these patients. Furthermore, both insulin-sensitizing and insulin-providing drug strategies for glycemic control appear to work equally well in patients with diabetes and stable coronary artery disease.

Results of the study were also presented June 7, 2009, at the ....

You must be a member to access this content. To continue reading, please enter your username and password above.

If you have not yet registered, we would like to take this opportunity to welcome you to TCTMD - The Source for Interventional Cardiovascular News & Education.

If you are already a member, please re-enter your username and password above, and then click LOGIN.

For questions regarding the registration process, please refer to our FAQ documentation or contact customer service.